Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.615
+0.055 (9.82%)
Feb 21, 2025, 4:10 PM AEST

ASX:PAR Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2015
Net Income
-58.65-51.91-39.25-34.3-12.3
Upgrade
Depreciation & Amortization
0.150.150.190.210.21
Upgrade
Stock-Based Compensation
1.20.943.273.211.28
Upgrade
Other Operating Activities
0.050.3-0.86-0.31-
Upgrade
Change in Accounts Receivable
1.290.361.79-5.050.02
Upgrade
Change in Accounts Payable
-9.345.072.12.20.75
Upgrade
Change in Other Net Operating Assets
-0.63-0.10.54-0.89-0.06
Upgrade
Operating Cash Flow
-65.94-45.19-32.21-34.93-10.09
Upgrade
Capital Expenditures
----0.03-0.13
Upgrade
Sale (Purchase) of Intangibles
----0-0
Upgrade
Investment in Securities
---0.75.75
Upgrade
Investing Cash Flow
---0.675.62
Upgrade
Long-Term Debt Repaid
-0.1-0.1-0.14-0.12-0.09
Upgrade
Total Debt Repaid
-0.1-0.1-0.14-0.12-0.09
Upgrade
Net Debt Issued (Repaid)
-0.1-0.1-0.14-0.12-0.09
Upgrade
Issuance of Common Stock
30.1266.40.211.1238.74
Upgrade
Other Financing Activities
-1.84-3.76---2.59
Upgrade
Financing Cash Flow
28.1862.530.07136.05
Upgrade
Foreign Exchange Rate Adjustments
-0.74-0.690.770.37-
Upgrade
Miscellaneous Cash Flow Adjustments
--0--
Upgrade
Net Cash Flow
-38.5116.66-31.36-32.8931.59
Upgrade
Free Cash Flow
-65.94-45.19-32.21-34.96-10.22
Upgrade
Free Cash Flow Margin
---40650.90%-170122.95%-
Upgrade
Free Cash Flow Per Share
-0.22-0.18-0.14-0.15-0.05
Upgrade
Cash Interest Paid
0.010.020.030.040.03
Upgrade
Cash Income Tax Paid
-7.33-7.4-9.53-3.37-3.62
Upgrade
Levered Free Cash Flow
-48.04-31.18-22.04-27.37-8.76
Upgrade
Unlevered Free Cash Flow
-48.03-31.17-22.02-27.34-8.74
Upgrade
Change in Net Working Capital
8.68-5.3-4.473.74-0.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.